M M Bortin|M M Horowitz - JoVE Visualize

Showing results (81-90 of 161) with videos related to

Pageof 17

Sort By:

Bone Marrow Transplantation|May 22, 2001

Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.

Statistics in Medicine|July 9, 1999

Modelling covariate adjusted mortality relative to a standard populationP K Andersen, M M Horowitz, J P Klein, et al.

British Journal of Haematology|December 1, 1987

Risk factors for acute graft-versus-host diseaseR P Gale, M M Bortin, D W van Bekkum, et al.

Leukemia|January 1, 1996

Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.

Bone Marrow Transplantation|May 10, 2016

Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTNB E Shaw, S J Lee, M M Horowitz, et al.

The New England Journal of Medicine|June 22, 2000

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell SourcesV Rocha, J E Wagner, K A Sobocinski, et al.

Blood|December 9, 1998

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.

The New England Journal of Medicine|October 20, 1994

Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countriesG Silberman, M G Crosse, E A Peterson, et al.

Bone Marrow Transplantation|May 13, 1998

Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?T M Waters, C L Bennett, T S Pajeau, et al.

Blood|November 15, 1995

Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemiaM J Hessner, D J Endean, J T Casper, et al.

Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:

Pageof 17

Bone Marrow Transplantation|May 22, 2001

Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.

Statistics in Medicine|July 9, 1999

Modelling covariate adjusted mortality relative to a standard populationP K Andersen, M M Horowitz, J P Klein, et al.

British Journal of Haematology|December 1, 1987

Risk factors for acute graft-versus-host diseaseR P Gale, M M Bortin, D W van Bekkum, et al.

Leukemia|January 1, 1996

Chemotherapy versus transplants for acute myelogenous leukemia in second remissionR P Gale, M M Horowitz, J K Rees, et al.

Bone Marrow Transplantation|May 10, 2016

Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTNB E Shaw, S J Lee, M M Horowitz, et al.

The New England Journal of Medicine|June 22, 2000

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell SourcesV Rocha, J E Wagner, K A Sobocinski, et al.

Blood|December 9, 1998

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.

The New England Journal of Medicine|October 20, 1994

Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countriesG Silberman, M G Crosse, E A Peterson, et al.

Bone Marrow Transplantation|May 13, 1998

Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?T M Waters, C L Bennett, T S Pajeau, et al.

Blood|November 15, 1995

Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemiaM J Hessner, D J Endean, J T Casper, et al.

Pageof 17